---
title: "Webinar: Oncology Research and Care: Reimagining Digital Innovation"
description: Real-world data provide an opportunity for oncology researchers to develop a new class of objective and sensitive endpoints that are clinically meaningful.
image: https://landing.ametris.com/hubfs/AG_Marketing_Emails_Headers_Webinars_2021_OncologyResearchAndCare_OnDemand_FINAL_WEB.jpg
---

[![ActiGraph](https://landing.ametris.com/hs-fs/hubfs/ActiGraph-Logo-Reversed.png?width=3030&height=618&name=ActiGraph-Logo-Reversed.png "ActiGraph")](https://theactigraph.com/?hsLang=en)

## On-Demand Webinar

---

# Oncology Research and Care: Reimagining Digital Innovation

[![ActiGraph Logo](https://landing.ametris.com/hs-fs/hubfs/AG%20Brand/AG_Brand_Logo_PNG_WhiteAndRed.png?width=200&height=84&name=AG_Brand_Logo_PNG_WhiteAndRed.png "ActiGraph Logo")](https://theactigraph.com?hsLang=en)

[![VivoSense Logo](https://landing.ametris.com/hs-fs/hubfs/Emails/AG_Marketing_Partners_VivoSense_Logo.png?width=259&height=60&name=AG_Marketing_Partners_VivoSense_Logo.png "VivoSense Logo")](https://www.vivosense.com/)

ActiGraph CEO, Jeremy Wyatt joins a panel of thought leaders from [VivoSense](https://www.vivosense.com/), [Covance](https://www.labcorpclinicaltrials.com/en-us/), [Keck School of Medicine of USC](https://keck.usc.edu/), and [Moffitt Cancer Center](https://moffitt.org/) to discuss how they are successfully deploying wearable and remote monitoring technologies to improve clinical outcomes in patients living with cancer. They also discuss the reasons behind, and the missed opportunities from, the slow adoption of such tools.

---

### Featured Speakers:

[![Jeremy Wyatt](https://landing.ametris.com/hs-fs/hubfs/Emails/JeremyWyatt.png?width=125&height=125&name=JeremyWyatt.png "Jeremy Wyatt")](https://www.linkedin.com/in/wjwyatt/)

[![Kate Lyden](https://landing.ametris.com/hs-fs/hubfs/Emails/KateLyden.png?width=125&height=125&name=KateLyden.png "Kate Lyden")](https://www.linkedin.com/in/kate-lyden-phd-43629791/)

##### Jeremy Wyatt

###### CEO

###### **ActiGraph**

##### Kate Lyden, PhD

###### Chief Science Officer

###### **VivoSense**

[![Ariel Aguilo](https://landing.ametris.com/hs-fs/hubfs/AG_Pictures_Headshots_Partners_ArielAguilo-Circled.png?width=125&height=125&name=AG_Pictures_Headshots_Partners_ArielAguilo-Circled.png "Ariel Aguilo")](https://www.linkedin.com/in/ariel-e-aguil%C3%B3-330b0482/)

[![Jorge Nieva](https://landing.ametris.com/hs-fs/hubfs/AG_Pictures_Headshots_Partners_JorgeNieva-Circled.png?width=125&height=125&name=AG_Pictures_Headshots_Partners_JorgeNieva-Circled.png "Jorge Nieva")](https://www.linkedin.com/in/jorge-nieva-855004a/)

##### Ariel Aguiló, MD

###### Executive Medical Director

###### **Covance**

##### Jorge Nieva

###### Associate Professor of Clinical Medicine

###### **Keck School of Medicine of USC**

[![Heather Jim](https://landing.ametris.com/hs-fs/hubfs/AG_Pictures_Headshots_Partners_HeatherJim-Circled.png?width=125&height=125&name=AG_Pictures_Headshots_Partners_HeatherJim-Circled.png "Heather Jim")](https://www.linkedin.com/in/heather-jim-8838a4135/)

##### Heather Jim Ph.D.

###### Senior Member and Co-Leader

###### **Health Outcomes and Behavior Program Moffitt Cancer Center**

---

Duration: **1 Hour**

![](https://px.ads.linkedin.com/collect/?pid=196258&fmt=gif)